The issues aren’t necessarily black and white, and there’s a variety of perspectives and nuances that need to be taken into account in order to make true change.
Rising prescription drug prices have been a concern in the United States for many decades; a report by the RAND corporation quantifies that U.S drug prices are 2.56 times higher than other developed countries labeled by the OECD, concluding that the US spends more on
Covid-19 served as an exposé on the inequities in our healthcare system. Indeed, during the peak of the pandemic, black Americans died nearly twice the rate of white Americans from the pandemic causing virus [1]. The pandemic was a tragedy for all Americans — there’s
Lower Income: One factor that must be considered when supplementing stewardship programs is considering the effects of lower income status on antibiotic overuse. Master of public health Connor Volpi and his colleagues analyze the income of a county in the United States and the frequency
According to the World Health Organization, antimicrobial resistance occurs as a result of adaptations from bacteria, leading to their unresponsiveness to medicines, making infections “harder to treat” and “increasing the risk of disease spread, severe illness, and death”; thus, antimicrobial resistance (AMR) is one of
Causes: Patent Times, Lobbying, or a Multifaceted issue? Dr. Vincent Rajkumar, an MD researching underneath the Mayo Clinic with experience working with pharmaceutical drugs and co-chair of the American Society of Hematology, suggests four reasons for status quo high prescription drug costs: the lack of
Former United States Surgeon General and renowned pediatric physician Dr. C. Everett Koop once deftly quipped that though healthcare is vital to all of us some of the time, public health is vital to all of us all of the time. Public health refers to
Covid-19 served as an exposé on the inequities in our healthcare system. Indeed, during the peak of the pandemic, black Americans died nearly twice the
Rising prescription drug prices have been a concern in the United States for many decades; a report by the RAND corporation quantifies that U.S drug
Causes: Patent Times, Lobbying, or a Multifaceted issue? Dr. Vincent Rajkumar, an MD researching underneath the Mayo Clinic with experience working with pharmaceutical drugs and
Copyright © 2023 . Your Health Matters . All Rights Reserved